Treating Hodgkin and non-Hodgkin lymphoma with proton therapy
Proton therapy is different from photon-based radiotherapy. Because of their unique physical properties, protons have no ‘exit’ dose and very little ‘entrance’...
Proton therapy is different from photon-based radiotherapy. Because of their unique physical properties, protons have no ‘exit’ dose and very little ‘entrance’...
This is a study protocol details a randomized trial taking place in Thailand with multiple centers comparing IMPT and IMRT for stage II–IVA squamous thoracic...
This systematic review evaluated eight studies and 401 patients with early stage NSCLC treated with hypofractionated PBT to a median total dose of 63 Gy(RBE)...
163 consecutively treated patients with biopsy-proven, stage III NSCLC who received IMPT (n = 35, 21%) or IMRT (n = 128, 79%) were analyzed in this study...
The Texas Center for Proton Therapy brings an advanced cancer treatment to North Texas that offers more hope to cancer patients. The 63,000-square-foot center...
The Willis-Knighton Health System, headquartered in Shreveport, Louisiana, is a not-for-profit community healthcare corporation with four general acute care...